These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Clinical aspects and treatment of primary focal segmental glomerulosclerosis and hyalinosis].
    Author: Diadyk AI, Vasilenko IV, Shpilevaia NI, Siniachenko OV, Kobets VG.
    Journal: Vrach Delo; 1989 Mar; (3):82-4. PubMed ID: 2750133.
    Abstract:
    The authors studied the clinico-laboratory values and efficacy of pathogenetic treatment in 8 patients with primary segmental glomerulosclerosis and hyalinosis (PSGH). The disease is characterized by distinct disorders in the T-system immunity. Glucocorticoid treatment did not essentially effect the course of PSGH. Cyclophosphane treatment allowed to achieve essential stable clinical improvement in certain patients.
    [Abstract] [Full Text] [Related] [New Search]